Cargando...
Advances in new drug therapies for the management of sickle cell disease
INTRODUCTION: Sickle cell disease (SCD) is an orphan disease in the United States, but is highly prevalent worldwide. Only two drugs, hydroxyurea and L-glutamine, are approved for this disease. With an improved understanding of the pathophysiology of SCD as well as the success of several recently ap...
Gardado en:
| Publicado en: | Expert Opin Orphan Drugs |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6411095/ https://ncbi.nlm.nih.gov/pubmed/30873300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2018.1471983 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|